DAX Reaches New All-Time Highs; Is An Ending Diagonal Nearing Completion?
The DAX surged to new all-time highs, targeting the 27,000-28,000 range. Despite the momentum, technical indicators...
Democrats’ midterm gains signal tighter AI data center oversight, pressuring infrastructure stocks while the SPDR S&P 500 ETF stays flat.
Rising credit default swaps signaled the AI selloff months before equity markets caught up.
Q3 earnings for the S&P 500 are tracking toward 26.6% growth as positive revisions bolster the 2027 outlook.
Negative real wages in 2026 are squeezing households as energy costs outpace pay raises.
Rising inflation sentiment and climbing PCE data suggest price pressures are becoming entrenched, potentially forcing a more hawkish Federal Reserve response.
The DAX surged to new all-time highs, targeting the 27,000-28,000 range. Despite the momentum, technical indicators...
Small businesses face greater exposure to rising interest rates, with 20% reporting financing cost impacts compared to...
PagSeguro Digital offers a projected 25% total return, combining a high 14.15% dividend yield with steady price...
A weakened U.S. administration and renewed Congressional oversight now provide leverage to resolve long-standing trade...
Anthropic’s public debut coincides with a sharp decline in AI token prices, creating a complex margin landscape.
The DAX surged to new all-time highs, targeting the 27,000-28,000 range. Despite the momentum, technical indicators signal a potential ending diagonal, suggesting the current bullish advance may be nearing exhaustion.
Small businesses face greater exposure to rising interest rates, with 20% reporting financing cost impacts compared to 12% of large firms.
PagSeguro Digital offers a projected 25% total return, combining a high 14.15% dividend yield with steady price recovery.
October’s Nonfarm Payrolls report will dictate the Fed's December rate path as markets eye a 65K job gain.
The S&P 500 index is consolidating near 7,700 after a relief rally triggered by midterm election results.
The Bank of England raised interest rates to 4.0% in a hawkish, unanimous decision that signaled further tightening ahead.
Novo Nordisk raised its 2026 outlook as surging obesity drug demand fuels growth, despite heavy impairment charges.